Hepatitis C Virus Core Antigen Test in Monitoring of Dialysis Patients

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Genotype</td><td align="center"> </td></tr><tr><td align="left"> 1b</td><td align="center">19</td></tr><tr><td align="left"> 2</td><td align="center">1</td></tr><tr><td align="left">HCVcAg positive</td><td align="center">18</td></tr><tr><td align="left">HBsAg-positive</td><td align="center">2</td></tr><tr><td align="left">HBsAb-positive or HBcAb-positive</td><td align="center">18</td></tr><tr><td align="left">HIV-Ab positive</td><td align="center">1</td></tr><tr><td align="left">Haemodialysis/peritoneal dialysis</td><td align="center">17/9</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Principal features of  20 HCVRNA positive patients. 

Hepatitis Research and Treatment

tab2

Table 2

Table 2: Hepatitis C Virus Core Antigen Test in Monitoring of Dialysis Patients 